245 related articles for article (PubMed ID: 25987655)
1. Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.
Fernandez CA; Smith C; Yang W; Mullighan CG; Qu C; Larsen E; Bowman WP; Liu C; Ramsey LB; Chang T; Karol SE; Loh ML; Raetz EA; Winick NJ; Hunger SP; Carroll WL; Jeha S; Pui CH; Evans WE; Devidas M; Relling MV
Blood; 2015 Jul; 126(1):69-75. PubMed ID: 25987655
[TBL] [Abstract][Full Text] [Related]
2.
Liu S; Gao C; Wu Y; Lin W; Li J; Xue T; Wang L; Zheng H; Zhang R
Pharmacogenomics; 2021 Nov; 22(17):1135-1142. PubMed ID: 34747637
[No Abstract] [Full Text] [Related]
3. HLA-DRB1*07:01-HLA-DQA1*02:01-HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia.
Kutszegi N; Yang X; Gézsi A; Schermann G; Erdélyi DJ; Semsei ÁF; Gábor KM; Sági JC; Kovács GT; Falus A; Zhang H; Szalai C
Haematologica; 2017 Sep; 102(9):1578-1586. PubMed ID: 28596278
[TBL] [Abstract][Full Text] [Related]
4. Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008.
Højfeldt SG; Wolthers BO; Tulstrup M; Abrahamsson J; Gupta R; Harila-Saari A; Heyman M; Henriksen LT; Jónsson ÒG; Lähteenmäki PM; Lund B; Pruunsild K; Vaitkeviciene G; Schmiegelow K; Albertsen BK;
Br J Haematol; 2019 Feb; 184(3):405-417. PubMed ID: 30450575
[TBL] [Abstract][Full Text] [Related]
5. HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.
Fernandez CA; Smith C; Yang W; Daté M; Bashford D; Larsen E; Bowman WP; Liu C; Ramsey LB; Chang T; Turner V; Loh ML; Raetz EA; Winick NJ; Hunger SP; Carroll WL; Onengut-Gumuscu S; Chen WM; Concannon P; Rich SS; Scheet P; Jeha S; Pui CH; Evans WE; Devidas M; Relling MV
Blood; 2014 Aug; 124(8):1266-76. PubMed ID: 24970932
[TBL] [Abstract][Full Text] [Related]
6. Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy.
Liu Y; Fernandez CA; Smith C; Yang W; Cheng C; Panetta JC; Kornegay N; Liu C; Ramsey LB; Karol SE; Janke LJ; Larsen EC; Winick N; Carroll WL; Loh ML; Raetz EA; Hunger SP; Devidas M; Yang JJ; Mullighan CG; Zhang J; Evans WE; Jeha S; Pui CH; Relling MV
Clin Pharmacol Ther; 2017 Jul; 102(1):131-140. PubMed ID: 28090653
[TBL] [Abstract][Full Text] [Related]
7. Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase Hypersensitivity.
Liu Y; Yang W; Smith CA; Cheng C; Karol SE; Larsen EC; Winick N; Carroll WL; Loh ML; Raetz EA; Hunger SP; Winter SS; Dunsmore KP; Devidas M; Yang JJ; Evans WE; Jeha S; Pui CH; Inaba H; Relling MV
Clin Pharmacol Ther; 2021 Sep; 110(3):794-802. PubMed ID: 33768542
[TBL] [Abstract][Full Text] [Related]
8. Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group.
Rau RE; Dreyer Z; Choi MR; Liang W; Skowronski R; Allamneni KP; Devidas M; Raetz EA; Adamson PC; Blaney SM; Loh ML; Hunger SP
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29090524
[TBL] [Abstract][Full Text] [Related]
9. HLA alleles associated with asparaginase hypersensitivity in Chinese children.
Chua GT; Rosa Duque JS; Cheuk DKL; Leung AWK; Wong WHS; Liu APY; Lee PPW; Ha SY; Chiang AKS; Ho MHK; Chu WK; Chan YS; Luk CW; Ling ASC; Kwan MYW; Yiu OKF; Wong ICK; Lau YL; Li CK; Leung WH; Chan GCF; Ip P; Kwok J
J Hematol Oncol; 2021 Oct; 14(1):182. PubMed ID: 34717720
[TBL] [Abstract][Full Text] [Related]
10. Detection of anti-asparaginase antibodies during therapy with E.coli asparaginase in children with newly diagnosed acute lymphoblastic leukemia and lymphoma.
Ebeid EN; Kamel MM; Ali BA
J Egypt Natl Canc Inst; 2008 Jun; 20(2):127-33. PubMed ID: 20029468
[TBL] [Abstract][Full Text] [Related]
11. Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort.
Nicoletti P; Carr DF; Barrett S; McEvoy L; Friedmann PS; Shear NH; Nelson MR; Chiriac AM; Blanca-López N; Cornejo-García JA; Gaeta F; Nakonechna A; Torres MJ; Caruso C; Valluzzi RL; Floratos A; Shen Y; Pavlos RK; Phillips EJ; Demoly P; Romano A; Blanca M; Pirmohamed M
J Allergy Clin Immunol; 2021 May; 147(5):1830-1837.e15. PubMed ID: 33058932
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia.
Rajić V; Debeljak M; Goričar K; Jazbec J
Leuk Lymphoma; 2015; 56(11):3103-8. PubMed ID: 25697915
[TBL] [Abstract][Full Text] [Related]
13. Genetic inhibition of NFATC2 attenuates asparaginase hypersensitivity in mice.
Rathod S; Ramsey M; Finkelman FD; Fernandez CA
Blood Adv; 2020 Sep; 4(18):4406-4416. PubMed ID: 32931581
[TBL] [Abstract][Full Text] [Related]
14. Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients.
Abaji R; Gagné V; Xu CJ; Spinella JF; Ceppi F; Laverdière C; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
Oncotarget; 2017 Jul; 8(27):43752-43767. PubMed ID: 28574850
[TBL] [Abstract][Full Text] [Related]
15. Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia.
Woo MH; Hak LJ; Storm MC; Evans WE; Sandlund JT; Rivera GK; Wang B; Pui CH; Relling MV
Leukemia; 1998 Oct; 12(10):1527-33. PubMed ID: 9766495
[TBL] [Abstract][Full Text] [Related]
16. Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity.
Chen SH; Pei D; Yang W; Cheng C; Jeha S; Cox NJ; Evans WE; Pui CH; Relling MV
Clin Pharmacol Ther; 2010 Aug; 88(2):191-6. PubMed ID: 20592726
[TBL] [Abstract][Full Text] [Related]
17. Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity.
Kutszegi N; Semsei ÁF; Gézsi A; Sági JC; Nagy V; Csordás K; Jakab Z; Lautner-Csorba O; Gábor KM; Kovács GT; Erdélyi DJ; Szalai C
PLoS One; 2015; 10(10):e0140136. PubMed ID: 26457809
[TBL] [Abstract][Full Text] [Related]
18. The Incidence of Hypersensitivity Reactions to Pegylated Asparaginase in Children With Acute Lymphoblastic Leukemia: A City-wide Experience.
Alrazzak M; Beaupin LK; Kinyoun P; Barth M
J Pediatr Hematol Oncol; 2016 Jan; 38(1):e16-20. PubMed ID: 26558809
[TBL] [Abstract][Full Text] [Related]
19. Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia.
Finch ER; Smith CA; Yang W; Liu Y; Kornegay NM; Panetta JC; Crews KR; Molinelli AR; Cheng C; Pei D; Ramsey LB; Karol SE; Inaba H; Sandlund JT; Metzger M; Evans WE; Jeha S; Pui CH; Relling MV
Pediatr Blood Cancer; 2020 Jan; 67(1):e28040. PubMed ID: 31612640
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the Frequencies of
Ali AM; Adam H; Hailu D; Howe R; Abula T; Coenen MJH
Appl Clin Genet; 2023; 16():131-137. PubMed ID: 37551203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]